Navigation Links
European hematologist receives award to conduct research in US
Date:3/30/2010

The European Hematology Association (EHA) and the American Society of Hematology (ASH) have selected Ingmar Bruns, MD, as the seventh recipient of the EHA-ASH Research Exchange Award, which serves to strengthen ties between North American and European scientific communities.

Dr. Ingmar Bruns is a resident physician and research scientist in the Department of Hematology, Oncology, and Clinical Immunology at the University of Dsseldorf in Germany. After graduating from medical school, he became interested in hematopoietic stem cell biology during his residency in hematology. His experiments in the laboratory led to the detection of the receptors for the hypothalamic peptides orexin A and B on hematopoietic stem cells, which serve as the basis for Dr. Bruns' project, "The Role of the Hypothalamic Peptides Orexin A and B and Their Receptors in the Regulation of Hematopoietic Stem Cell Behavior," which he will be conducting in the laboratory of Paul Frenette, MD, at Mount Sinai School of Medicine, New York, NY. Dr. Frenette's scientific approach and the methodology utilized in his laboratory will provide an ideal environment for Dr. Bruns' research interests. Participating in the award program will enable Dr. Bruns to return to Dsseldorf to start an independent junior research group.

"I was totally surprised to be selectedgiven the competitive situation," said Dr. Bruns. "I felt honored andvery happy, as it provides a great opportunity."

The EHA-ASH Research Exchange Award provides hematologists in training or in the early phase of their careers with the opportunity to pursue research in a new environment, gaining invaluable experience. European awardees select a North American institution at which to conduct their research, and the same opportunity is provided to North American awardees to pursue research in Europe. Awardees receive 75,000 to fund their research. The fellowship, which encourages increased collaboration between scientists, also grants recipients additional travel stipends to attend either the EHA or ASH annual meetings.


'/>"/>

Contact: Patrick C. Irelan
pirelan@hematology.org
202-776-0544
American Society of Hematology
Source:Eurekalert

Related medicine news :

1. European Cancer Organization supports a revision of the EU Clinical Trials Directive
2. Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
3. Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)
4. Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan
5. The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center
6. Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study
7. Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems
8. Lower detection of prostate cancer with PSA screening in US than in a European randomized trial
9. Your e-Marketing Journey in 2010: An e-Book for Corporate Communicators Working in European Headquarters
10. United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension
11. International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... , ... January 16, 2017 , ... ... availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:1/16/2017)... ... ... well-aware of the following facts at present:, Flu and cold ... effect on keeping this particularly bad strain of the flu away , In ... , These facts are well-known among the team at Woodard! About halfway ...
(Date:1/16/2017)... Hills, CA (PRWEB) , ... January 16, 2017 ... ... a manuscript in the Aesthetic Surgery Journal , the official journal of ... he conducted on lower eyelid retraction surgery. The procedure is designed to correct ...
(Date:1/16/2017)... ... 16, 2017 , ... One thing common to all types of cancer is ... as well. The money spent screening for and treating cancer in the United States ... for cancer more than in any other country that has an advanced healthcare system, ...
(Date:1/16/2017)... ... January 16, 2017 , ... Vixiar Medical, Inc. ... the medical device company, effective immediately. , “This is perfect timing for Kevin ... strong track record in medical device market development and revenue growth, particularly in ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... , January 13, 2017 On ... Jones Industrial Average, and the S&P 500 edged lower ... ended Thursday,s trading session in bearish territories. Taking into ... Services equities this morning: Myriad Genetics Inc. (NASDAQ: ... ), INC Research Holdings Inc. (NASDAQ: INCR ...
(Date:1/13/2017)... NEW YORK , Jan. 12, 2017 /PRNewswire-USNewswire/ ... type 1 diabetes (T1D) research, is pleased to ... advocacy efforts, the Centers for Medicare & Medicaid ... devices approved by the FDA for use in ... a significant step toward making them eligible for ...
(Date:1/13/2017)... YORK , Jan. 12, 2017  Rosen Law ... filing of a class action lawsuit on behalf of ... ALXN ) from February 10, 2014 through November 9, ... recover damages for Alexion investors under the federal securities ... go to http://rosenlegal.com/cases-991.html or call Phillip ...
Breaking Medicine Technology: